Conference
updates

• Presentations and speech of Minister Onkelinx available now
  
  The different conference presentations available for publication are now on the website. The speech of Minister Onkelinx, who was unfortunately not able to join us, is also available.
  
  
  
  

• The Belgian Pharmaceutical Conference : latest update on clinical studies in Belgium and new recommendations for the decision makers
  
  Since the bumper year of 2008, systematically fewer patients are able to take part in clinical studies in Belgium. The drop in Belgium is in line with the decline of clinical studies in Europe. This trend is severely impairing the number of patients who benefit from taking part in the earliest stage of treatment involving innovative medicines. After a constant rise of the number of clinical studies in Belgium over the years, this downward spiral is sounding the alarm bell. High time to act. During the Belgian Pharmaceutical Conference PricewaterhouseCoopers' Ingrid Maes, together with the FAMHP's dr. Greet Musch, who is chairing the second plenary session, presents not only an in-depth analysis of the state of affairs of clinical studies in Belgium, she also puts forward recommendations aimed at safeguarding this type of research that is essential for Belgian patients and our knowledge-based economy.
  
  >> Read more (Nl)     >> Read more (Fr)
  
  

• Registrations exceed today 300 participants
  
  Register now online to secure your place and don’t miss the opportunity to be part of the Conference.
  
  

• Galenus Award Ceremony in co-operation with Artsenkrant/Le Journal du Médecin
  
  We are proud to announce the 2012 Belgian pharmaceutical conference is hosting the Galenus Award Ceremony, partnered by Artsenkrant/Journal du médecin. The Prime Minister, Mr. Elio Di Rupo, has confirmed to open the academic session of the Galenus Award, an important recognition for pharmaceutical research and the innovative pharmaceutical industry.
  
  
  
  
  
  

• Societal focus on medicines : Pharma/Healthcare and the Econoshock
  
  The economic upheavals of the recent past will demand some significant adjustments from the pharmaceutical industry. “The next pharma generation will have to adapt to the 2030 healthcare ecosystem”, confirms expert Geert Noels, CEO of Econopolis. Different strategies will be highlighted during the Conference to prepare for this economic challenges.
  
  >> Read more
  
  

• 'The Impatient Patient©' : discover the topic during the Belgian Pharmaceutical Conference on April 17, 2012.
  
  The organizers BeAPP, BAPU and pharma.be present the final program and an overview of the top notch speakers.
  
  >> Read more
  
  

• Conference main partners explain why : new video online
  
  Watch now our new video of main partners Novartis, Novellas Healthcare and PwC. Together they underline the importance of the Belgian Pharmaceutical Conference and  its’ central theme : 'The Impatient Patient©'.  PWC also highlights Clinical Trials as a major concern  for the Belgian healthcare sector.

  
  
  

• Vice-prime minister Onkelinx accepts to open the conference
  
  Laurette Onkelinx, the Belgian minister of public health, has confirmed her attendance for the Grand opening of the Belgian pharmaceutical conference. For more program updates click here. View also the speakers’ section and discover their autobiographies.

  
  
  

• New press release about the launch of our conference website
  
  Click here to view the press release that highlights the 2012 Umbrella theme ‘The Impatient Patient©’, the program, the top speakers and the closing Galenus Award ceremony.

  
  
  

• Why attend the conference : new video online
  
  Watch the new footage of conference organizers Monique Podoor from BeAPP and Leo Neels from pharma.be. Together they highlight the main focus of the Belgian Pharmaceutical Conference on April 17, ‘The Impatient Patient’. A short overview of the program, key note speakers and the broad networking scope of the event are also highlighted.